Evolus, Inc. (EOLS): Price and Financial Metrics
Evolus, Inc. (EOLS)
Today's Latest Price: $11.29 USD
0.12 (1.07%)
Updated Jan 17 12:00am
Add EOLS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
EOLS Stock Summary
- EOLS's went public 1.94 years ago, making it older than just 4.59% of listed US stocks we're tracking.
- With a year-over-year growth in debt of 472.15%, Evolus Inc's debt growth rate surpasses 95.46% of about US stocks.
- Revenue growth over the past 12 months for Evolus Inc comes in at 569.75%, a number that bests 98.82% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Evolus Inc are APHA, ADES, QD, JT, and NBEV.
- Visit EOLS's SEC page to see the company's official filings. To visit the company's web site, go to www.evolus.com.
EOLS Daily Price Range
EOLS 52-Week Price Range
EOLS Stock Price Chart More Charts
EOLS Price/Volume Stats
| Current price | $11.29 | 52-week high | $30.25 |
| Prev. close | $11.17 | 52-week low | $10.31 |
| Day low | $11.14 | Volume | 685,100 |
| Day high | $11.73 | Avg. volume | 873,208 |
| 50-day MA | $12.72 | Dividend yield | N/A |
| 200-day MA | $16.33 | Market Cap | 377.37M |
Evolus, Inc. (EOLS) Company Bio
Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is based in Irvine, California.
Top Stories View All
3 Vital Investing Strategies
Best & Worst Performing Stock Industries for January 17, 2020
Best & Worst Performing Small Cap Stocks for January 17, 2020
Best & Worst Performing Mid Cap Stocks for January 17, 2020
Best & Worst Performing Large Cap Stocks for January 17, 2020
View All Top Stories
Loading social stream, please wait...